Akiferidin suppresses cervical cancer growth and angiogenesis via the VEGF/DLL4-Notch pathway
Cervical cancer remains a major gynecological malignancy with a substantial global burden, particularly in low- and middle-income regions. Tumor angiogenesis driven by the VEGF/DLL4–Notch axis promotes cervical cancer progression, and the anti-VEGF antibody bevacizumab shows limited clinical benefit...
Na minha lista:
| Principais autores: | , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Frontiers Media S.A.
2026-04-01
|
| Serier: | Frontiers in Pharmacology |
| Fag: | |
| Online adgang: | https://www.frontiersin.org/articles/10.3389/fphar.2026.1803135/full |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|